Duke University Medical Center
SCCM Discovery Critical Care Innovation Incubator
Saturday, March 21, 2026
7:00 AM - 7:00 PM Central Time
Disclosure(s): Merck Sharp & Dohme Inc.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Synappse: Owner/Co-Owner Founder/Co-Founder (Ongoing)
Evaluation of APACHE IV Performance and Drift in Patients With Sepsis Across Diverse Ethnicities
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure(s): Merck Sharp & Dohme Inc.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Synappse: Owner/Co-Owner Founder/Co-Founder (Ongoing)
Beyond the Hype: Implementing Technologies, AI, and ML in Critical Care
Monday, March 23, 2026
3:15 PM - 4:15 PM Central Time
Disclosure(s): Merck Sharp & Dohme Inc.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Synappse: Owner/Co-Owner Founder/Co-Founder (Ongoing)
Evaluating Serum Magnesium Response and Its Predictors After IV Magnesium in Critically ill Patients
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure(s): Merck Sharp & Dohme Inc.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Synappse: Owner/Co-Owner Founder/Co-Founder (Ongoing)
Effectiveness of Blood Transfusions and Predictors of Response in Critically ill Patients
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure(s): Merck Sharp & Dohme Inc.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Synappse: Owner/Co-Owner Founder/Co-Founder (Ongoing)
